HK1047750A1 - 趨化因子受體拮抗劑 - Google Patents

趨化因子受體拮抗劑

Info

Publication number
HK1047750A1
HK1047750A1 HK03100033.6A HK03100033A HK1047750A1 HK 1047750 A1 HK1047750 A1 HK 1047750A1 HK 03100033 A HK03100033 A HK 03100033A HK 1047750 A1 HK1047750 A1 HK 1047750A1
Authority
HK
Hong Kong
Prior art keywords
receptor antagonists
chemokine receptor
chemokine
antagonists
receptor
Prior art date
Application number
HK03100033.6A
Other languages
English (en)
Inventor
Chu Min
A Mierzwa Ronald
Terracciano Joseph
G Patel Mahesh
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of HK1047750A1 publication Critical patent/HK1047750A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pyrrole Compounds (AREA)
HK03100033.6A 2000-03-30 2003-01-03 趨化因子受體拮抗劑 HK1047750A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19333100P 2000-03-30 2000-03-30
PCT/US2001/010018 WO2001074772A1 (en) 2000-03-30 2001-03-28 Chemokine receptor antagonists

Publications (1)

Publication Number Publication Date
HK1047750A1 true HK1047750A1 (zh) 2003-03-07

Family

ID=22713200

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03100033.6A HK1047750A1 (zh) 2000-03-30 2003-01-03 趨化因子受體拮抗劑

Country Status (9)

Country Link
US (1) US6476062B2 (zh)
EP (1) EP1268420A1 (zh)
JP (1) JP2003529585A (zh)
CN (1) CN1422252A (zh)
AU (1) AU2001249573A1 (zh)
CA (1) CA2404312A1 (zh)
HK (1) HK1047750A1 (zh)
MX (1) MXPA02009660A (zh)
WO (1) WO2001074772A1 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6962943B2 (en) * 2001-11-21 2005-11-08 Aventis Pharma Deutschland Gmbh Gabusectin derivatives, processes for preparing them and their use
DE10156906A1 (de) * 2001-11-21 2003-05-28 Aventis Pharma Gmbh Gabusectin-Derivate, Verfahren zu deren Herstellung und deren Verwendung
US9101628B2 (en) 2007-09-18 2015-08-11 The Board Of Trustees Of The Leland Stanford Junior University Methods and composition of treating a flaviviridae family viral infection
JP5715820B2 (ja) * 2007-09-18 2015-05-13 スタンフォード ユニバーシティー フラビウイルス科ファミリーのウイルスへの感染を治療する方法ならびに、フラビウイルス科ファミリーのウイルスへの感染を治療するための組成物
US9149463B2 (en) * 2007-09-18 2015-10-06 The Board Of Trustees Of The Leland Standford Junior University Methods and compositions of treating a Flaviviridae family viral infection
US8940730B2 (en) 2007-09-18 2015-01-27 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions of treating a Flaviviridae family viral infection
JP2012520884A (ja) 2009-03-18 2012-09-10 ザ ボード オブ トラスティーズ オブ ザ リランド スタンフォード ジュニア ユニバーシティー フラビウイルス科ウイルス感染症を治療する方法および組成物
BR112013032911A2 (pt) 2011-06-19 2017-01-24 Univ New York leucotoxina e/d como um novo agente anti-inflamatório e microbicida
US11629196B2 (en) 2020-04-27 2023-04-18 Incelldx, Inc. Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7118100A (zh) * 1971-01-07 1972-07-11 Sandoz Ag
US5951974A (en) 1993-11-10 1999-09-14 Enzon, Inc. Interferon polymer conjugates
TW517067B (en) 1996-05-31 2003-01-11 Hoffmann La Roche Interferon conjugates
US5759842A (en) * 1996-10-24 1998-06-02 Merck & Co., Inc. In vitro HIV integrase inhibitors
US6124327A (en) * 1997-07-29 2000-09-26 Merck & Co., Inc. HIV integrase inhibitors

Also Published As

Publication number Publication date
WO2001074772A1 (en) 2001-10-11
AU2001249573A1 (en) 2001-10-15
US6476062B2 (en) 2002-11-05
MXPA02009660A (es) 2003-03-10
EP1268420A1 (en) 2003-01-02
US20020128307A1 (en) 2002-09-12
CN1422252A (zh) 2003-06-04
CA2404312A1 (en) 2001-10-11
JP2003529585A (ja) 2003-10-07

Similar Documents

Publication Publication Date Title
IL153308A0 (en) Thrombin receptor antagonists
IL152775A0 (en) Il-8 receptor antagonists
EP1254116A4 (en) ALPHA V INTEGRIN RECEPTOR ANTAGONISTS
EP1252162A4 (en) ALPHA V INTEGRIN RECEPTOR ANTAGONISTS
DZ3309A1 (en) Il-8 receptor antagonists
IL151431A0 (en) Il-8 receptor antagonists
AU9259801A (en) Alpha v integrin receptor antagonists
EP1296958A4 (en) ANTIAGONISTS OF NMDA NR2B RECEPTORS OF IMINOPYRIMIDINE
EP1274415A4 (en) IL-8 RECEPTOR ANTAGONISTS
HK1046414A1 (zh) 趨化因子受體ccr3拮抗劑
IL151210A0 (en) Il-8 receptor antagonists
HK1047750A1 (zh) 趨化因子受體拮抗劑
GB0028104D0 (en) Bombesin receptor antagonists
EP1265905A4 (en) IL-2 RECEPTOR ANTAGONISTS
EP1351687A4 (en) UROTENSIN II RECEPTOR ANTAGONISTS
GB0028146D0 (en) Bombesin receptor antagonists
EP1274413A4 (en) IL-8 RECEPTOR ANTAGONISTS
EP1274428A4 (en) INTERLEUKIN-8 (IL-8) RECEPTOR ANTAGONISTS
EP1263427A4 (en) ANTAGONISTS OF THE INTERLEUKIN 8 RECEPTOR
PL370367A1 (en) Ccr-3 receptor antagonists v
EP1261329A4 (en) IL-8 RECEPTOR ANTAGONISTS
GB0000474D0 (en) Receptor
AU1252102A (en) Receptor
GB0026327D0 (en) Thrombin receptor antagonists
AU9088401A (en) Alpha v integrin receptor antagonists